Preclinical evaluation of CPT-11 and its active metabolite SN-38

Seminars in Oncology

Volumn 23, Issue 1 SUPPL. 3, 1996, Pages 11-20

  Lavelle, F ^a   Bissery, M C ^a   Andre, S ^a   Roquet, F ^a   Riou, J F ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; IRINOTECAN;

ANTINEOPLASTIC ACTIVITY; CANCER RESISTANCE; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; EXPERIMENTAL NEOPLASM; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; DNA DAMAGE; DNA TOPOISOMERASES, TYPE I; DRUG RESISTANCE; ENZYME INHIBITORS; HUMANS; NEOPLASMS, EXPERIMENTAL;

EID: 0029931995     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (0)